Southern Adelaide Diabetes and Endocrine Services, Repatriation General Hospital, Adelaide, Australia.
J Bone Miner Res. 2013 Feb;28(2):412-8. doi: 10.1002/jbmr.1761.
Calcium supplements have been associated with an increased risk of cardiovascular events. However, the validity of these findings has been questioned. A major concern is that the mechanism underlying an increase in cardiovascular events has not been demonstrated. Calcium initiates cardiac and vascular contraction following influx of calcium into cardiac and smooth muscle from extracellular fluid. We have investigated whether the acute rise in serum calcium following calcium supplement administration is associated with adverse changes in cardiovascular function. In an open interventional study, we recruited 25 volunteers (16 female, age 60.3 ± 6.5 years, body mass index 25.7 ± 2.7 kg/m2) from the community who were not taking calcium supplements. Participants were studied before and 3 hours after a single oral dose of 1000 mg calcium citrate. We assessed well-validated markers of arterial stiffness (pulse wave velocity [PWV]), arterial wave reflection (augmentation index [AIx]), and myocardial perfusion (subendocardial viability ratio [SEVR]) by pulse wave analysis and endothelial function (reactive hyperemia index [RHI]) by peripheral arterial tonometry. Total and ionized serum calcium were acutely increased by 0.10 ± 0.07 and 0.06 ± 0.03 mmol/L, respectively, 3 hours after calcium citrate administration (p < 0.0001 for both comparisons). Following administration of calcium citrate there was a fall in AIx from a median of 29.7% (23.8% to 34.0%) to 26.4% (22.7% to 34.0%, p = 0.03) and an increase in SEVR from 163% (148% to 174%) to 170% (149% to 185%, p = 0.007). PWV and RHI were not significantly altered. The change in total calcium was negatively correlated with the change in AIx (r = -0.48, p = 0.02). In summary, the acute increase in serum calcium following calcium supplement administration is associated with reduced arterial wave reflection and a marker of increased myocardial perfusion. If maintained long-term, these changes would be expected to reduce cardiovascular risk. Acute serum calcium-mediated changes in these parameters of cardiovascular function are unlikely to underlie an association between calcium supplementation and cardiovascular events.
钙补充剂与心血管事件风险增加有关。然而,这些发现的有效性一直存在争议。一个主要的担忧是,心血管事件增加的机制尚未得到证明。钙从细胞外液流入心肌和平滑肌,引发心肌和血管收缩。我们研究了钙补充剂给药后血清钙的急性升高是否与心血管功能的不良变化有关。在一项开放的干预性研究中,我们从社区招募了 25 名志愿者(16 名女性,年龄 60.3±6.5 岁,体重指数 25.7±2.7kg/m2),他们没有服用钙补充剂。参与者在单次口服 1000mg 柠檬酸钙前后 3 小时接受了评估。我们通过脉搏波分析评估了动脉僵硬度(脉搏波速度 [PWV])、动脉波反射(增强指数 [AIx])和心肌灌注(心内膜下存活比 [SEVR])的公认标志物,通过外周动脉张力测定评估了内皮功能(反应性充血指数 [RHI])。钙柠檬酸给药后 3 小时,总血清钙和离子化血清钙分别急性增加 0.10±0.07mmol/L 和 0.06±0.03mmol/L(p<0.0001 两项比较)。服用柠檬酸钙后,AIx 从中位数 29.7%(23.8%至 34.0%)降至 26.4%(22.7%至 34.0%,p=0.03),SEVR 从 163%(148%至 174%)增加至 170%(149%至 185%,p=0.007)。PWV 和 RHI 没有明显变化。总钙的变化与 AIx 的变化呈负相关(r=-0.48,p=0.02)。总之,钙补充剂给药后血清钙的急性增加与动脉波反射降低和心肌灌注增加的标志物有关。如果长期保持,这些变化预计会降低心血管风险。急性血清钙介导的这些心血管功能参数的变化不太可能是钙补充剂与心血管事件之间关联的基础。